Nicholas Plugis

Senior Principal

2023 - Current

Principal

2020 - 2023

Senior Associate

2018 - 2020

Associate

2017 - 2018

Consultant

2016 - 2017

VentureLabs Fellow

2016 - 2016

Advisor

2022

Founding Team, Chief Innovation Officer

2017 - 2022

Cellarity develops novel medicines that are unreachable with traditional methods of drug discovery, completely revolutionizing the way drugs are created.

Advisor

2022 - 2023

Founding Team

2020 - 2022

Abiologics, Inc. is a privately held, early-stage biotechnology company on a mission to make biology better through chemistry. We are pioneering the development of a transformational new class of medicines that is unlocked by novel synthetic and computational technologies.

Founding Team

2021 - 2022

Ampersand Biomedicines enables a new way of designing programmable medicines that work precisely where needed in the body and nowhere else.

Founding Team

2017 - 2019

Founding Team

2017 - 2018

Ring Therapeutics is revolutionizing the gene therapy and nucleic acid medicine space by harnessing the most abundant and diverse member of the human commensal virome, anelloviruses.

Vice President

2015 - 2016

Scientific and Market Advising in the Life Sciences

Engagement Manager

2014 - 2015

Analyst

2013 - 2014

Research Assistant

2010 - 2011

Department of Chemistry and Biochemistry, Laboratory of Dr. James Larrabee

Research Assistant

2008 - 2009

Departments of Chemistry and Radiology, Laboratory of Dr. Peter Caravan